← back to search

J. Anderson

AbbVie (United States) · US
Area of research
Rheumatology · Immunology
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, and Autoimmune and Inflammatory Disorders Research.
h-index
22
citations
3,426
works
65
NIH funding
primary concept
email

Recent publications

Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
˜The œLancet. Gastroenterology & hepatology 2025cited by 22position: middledoi
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of <scp>ABBV</scp>‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial
Arthritis & Rheumatology 2025cited by 7position: middledoi
Efficacy and Safety of <scp>ABBV</scp> ‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial
Arthritis & Rheumatology 2025cited by 6position: middledoi
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
New England Journal of Medicine 2021cited by 296position: middledoi
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial
Journal of Allergy and Clinical Immunology 2019cited by 352position: middledoi
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial
Annals of the Rheumatic Diseases 2013cited by 121position: middledoi
Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
Arthritis Care & Research 2012cited by 759position: firstdoi

Grants

Collaborative Research: FW-HTF-RM: AI-Assisted Programming: Equipping Social and Natural Scientists for the Future of Research
NSF2326174$453,2662023–2027PIRePORTER
SPT-SLIM: A Line Intensity Mapping Pathfinder for the SPT
NSF2108763$1,095,6502021–2026PIRePORTER
Active Magnetosphere and Planetary Electrodynamics Response Experiment-III (AMPERE-III)
NSF2002574$6,517,4882020–2026PIRePORTER
EarthCube Data Capabilities: Collaborative Proposal: Assimilative Mapping of Geospace Observations
NSF1928358$217,4122019–2025PIRePORTER
PREEVENTS Track 2: Collaborative Research: Comprehensive Hazard Analysis for Resilience to Geomagnetic Extreme Disturbances
NSF1663885$282,9162017–2024PIRePORTER
AMPERE-II: Active Magnetosphere and Planetary Electrodynamics Response Experiment-II
NSF1420184$5,100,0002014–2020PIRePORTER
LTREB Renewal: Evolutionary Ecology of Seabird Reproductive Life Histories
NSF1354473$450,0002014–2020PIRePORTER
SEP Collaborative: Routes to Earth Abundant Kesterite-based Thin Film Photovoltaic Materials
NSF1230929$1,010,0002012–2017PIRePORTER
DISSERTATION RESEARCH: Genetic Polymorphism in Behavioral Traits in a Bird with Maltreatment of Young
NSF1110393$14,9742011–2014PIRePORTER
LTREB: Evolutionary Ecology of Seabird Reproductive Life Histories
NSF0842199$460,4002009–2015PIRePORTER
Career Development Workshops for New and Prospective Faculty
NSF0958554$48,8602009–2012PIRePORTER
AMPERE: Active Magnetosphere and Planetary Electrodynamics Response Experiment
NSF0739864$4,063,8382008–2013PIRePORTER
Technologies for Cooperative Learning in Rural India
NSF0633850$439,5672007–2011PIRePORTER
NSWP: Sustained Sub-auroral Storm Electric Fields: Polarization or Minimum Dissipation?
NSF0720114$299,8492007–2012PIRePORTER
MRI: Development: SWIMS--Standalone WIreless Magnetometer System
NSF0619609$720,9262006–2011PIRePORTER
Workshop on Complex Interacting Systems for a Sustainable Future
NSF0646894$99,6562006–2008PIRePORTER
Career Development Workshop for New Faculty
NSF0527829$64,0102005–2010PIRePORTER

Frequent collaborators

Aileen L. Pangan · Merck & Co., Inc., Rahway, NJ, USA (United States)3 papers (2013–2021)Julie Parmentier · AbbVie (United States)2 papers (2025–2025)Frank Buttgereit · Humboldt-Universität zu Berlin2 papers (2025–2025)Ronilda D’Cunha · University of Iowa2 papers (2025–2025) · 2 papers (2025–2025)Dilek Arikan · AbbVie (United States)2 papers (2025–2025)Weihan Zhao · University of Illinois Chicago2 papers (2025–2025)Jonathan I. Silverberg · Maimonides Medical Center1 papers (2019–2019)Patrick Zueger · AbbVie (United States)1 papers (2021–2021)Frank Behrens · Goethe University Frankfurt1 papers (2021–2021)Feng Huang · Chinese PLA General Hospital1 papers (2013–2013)Ernesto J. Muñoz‐Elías · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2025–2025)Huji Xu · Jiangsu University1 papers (2013–2013)Marla C. Dubinsky · Takeda (Japan)1 papers (2025–2025)Jiandong Lu · Guangzhou University of Chinese Medicine1 papers (2025–2025)Claire Owen · Monash Health1 papers (2025–2025)Henrique D. Teixeira · AbbVie (United States)1 papers (2019–2019)Mohamed‐Eslam F. Mohamed · AbbVie (United States)1 papers (2019–2019)Fadi Towfic · Predictive Science (United States)1 papers (2025–2025) · 1 papers (2025–2025)